Detalhe da pesquisa
1.
Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial.
Blood
; 142(8): 687-699, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390310
2.
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma.
Br J Haematol
; 199(1): 76-85, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861370
3.
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.
J Clin Oncol
; 39(31): 3441-3452, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310172